Latest news with #AbuDhabiGlobalHealthcareWeek
Al Etihad
15-05-2025
- Health
- Al Etihad
Zayed Higher Organization and Sakina partner to deliver specialised mental health services for People of Determination
15 May 2025 13:20 ABU DHABI (ALETIHAD)As part of its continuous efforts to develop care and rehabilitation services provided to various categories of People of Determination, Zayed Higher Organisation (ZHO) has partnered with Sakina, a subsidiary of PureHealth, to collaborate in providing specialised healthcare and therapeutic agreement was announced on the sidelines of the Abu Dhabi Global Healthcare Week held at ADNEC Centre Abu was signed on behalf of Zayed Higher Organisation by His Excellency Abdullah Al Humaidan, Secretary-General of the organisation, and on behalf of Sakina by Dr Zain Alyafei, Chief Executive Officer of Sakina. The signing ceremony was attended by several leaders from both the agreement, Zayed Higher Organisation will provide important information regarding the needs of People of Determination and their families, facilitate access to targeted psychological services through coordination with Sakina, and organise awareness activities and events to promote mental health awareness among is committed to providing specialised psychological services for beneficiaries. These include comprehensive assessments, training ZHO staff on the basics of psychological support and handling specific cases, ensuring confidentiality of personal data, and adhering to professional ethical standards. Sakina will also provide group or individual psychological support sessions, coordinate therapy groups with families, design suitable psychosocial rehabilitation programmes, and facilitate their implementation based on best addition, they will provide psychiatric follow-ups and medication prescriptions through licensed Excellency Al Humaidan said, "At Zayed Higher Organisation for People of Determination, we are keen to develop strategic partnerships with specialised entities to deliver integrated services that meet the needs of our beneficiaries. The agreement with Sakina reaffirms our commitment to providing comprehensive healthcare for People of Determination, which enhances our efforts to empower and integrate them into society and ensures them a dignified life. This strategic partnership will contribute to offering specialised healthcare tailored to the needs of our beneficiaries." Dr. Alyafei said, "At Sakina, we are committed to developing specialised care models based on the latest global best practices in mental health. This strategic partnership with Zayed Higher Organisation marks an important step toward delivering effective and comprehensive support to People of Determination and their families, within a therapeutic environment that meets their needs and upholds both scientific and human values."
Al Etihad
17-04-2025
- Business
- Al Etihad
Genomics, AI shape future of personalised, preventive healthcare in UAE
18 Apr 2025 00:27 SARA ALZAABI (ABU DHABI)The UAE has been making significant strides towards personalised, preventive healthcare — and behind the major projects in the sector are collaborations with global institutions and innovators. Genomics and artificial intelligence (AI) are playing a central role in shaping the future of health and enhancing patient-centred care, experts and delegates at the Abu Dhabi Global Healthcare Week (ADGHW) told Aletihad on Thursday. 'Genomics is a fundamental part of biology; understanding our genome helps us identify risks for diseases like cancer and heart conditions. It also shows us which medicines work best for each individual, said Jacob Thaysen, CEO of Illumina, an American biotech company. Illumina has been at the forefront of sequencing the entire UAE population's DNA, a groundbreaking project aimed at creating personalised health profiles. 'Now, our focus is on turning these insights into real steps to improve health and longevity,' Thaysen said. 'By understanding polygenic risk scores, people can take action to avoid diseases like cancer.'The UAE is the first country in the world to implement such a large-scale genomic project, Thaysen said. 'It is setting the stage for the future of healthcare worldwide.'Pharmaceutical firm Eli Lilly and Company is also among those who have established strong ties with UAE health authorities, particularly the Department of Health – Abu Dhabi.'We focus on three main therapeutic areas: diabetes, obesity, neurodegenerative diseases such as Alzheimer's, and oncology, particularly cancer,' said Nadim Hasbani, Head of Corporate Affairs Strategy, Middle East and Turkey areas at Eli Lilly and firm signed two partnerships with the DoH in 2024. 'The first is focused on Alzheimer's, to establish a Centre of Excellence in Abu Dhabi. The second MoU addresses obesity, exploring alternative solutions like medications instead of relying solely on surgery.'Meanwhile, healthcare provider Mediclinic — another participant at the ADGHW — is focused on promoting a healthcare system built around wellness. 'Prevention is better than cure. Mediclinic is absolutely committed to prevention and to ensuring a balanced healthcare ecosystem,' said Barry Bedford, COO for UAE at Mediclinic Middle East. Explaining the role of AI and technology in this mission, he said: 'AI can help us predict and prevent conditions—but we still need that compassionate human interaction between doctor and patient. Itis critical that we do not take the compassion out of healthcare.'
Asharq Al-Awsat
17-04-2025
- Health
- Asharq Al-Awsat
KFSHRC's Organ Transplant Center of Excellence Wins Innovation Award
King Faisal Specialist Hospital and Research Center (KFSHRC) Organ Transplant Center of Excellence (OTCoE) has received the Innovation Award in the Regional Institute Category at the Abu Dhabi Global Healthcare Week (ADGHW) 2025, in recognition of its pioneering contributions to transplant innovation and regional impact on patient care. Consultant of Transplant, Hepatobiliary, and Pancreatic Surgery Dr. Yasser Al Nemary accepted the award on behalf of OTCoE during the ADGHW ceremony held at the ADNEC Center in Abu Dhabi. Since 2011, OTCoE has performed more than 6,600 organ transplants, including kidney, liver, lung, and pancreas procedures, reaching a record high with 1,096 organ transplants. It has also achieved several surgical firsts, including the world's first fully robotic liver transplant and the region's first robotic pancreas transplant performed on a type 1 diabetes patient, SPA reported. With over 5,000 kidney transplants completed and 500 successful paired kidney exchanges under its pioneering Kidney Paired Donation Program, OTCoE is a regional and global reference for multidisciplinary collaboration and patient-centered innovation. "This award affirms our drive to transform organ transplant through innovation and precision, powered by a team relentlessly committed to advancing patient care," said OTCoE Executive Director Dr. Dieter Broering. The ADGHW Innovation Awards celebrate transformative achievements in healthcare, spotlighting institutions that improve patient outcomes, expand access, and drive progress through innovation. For the third consecutive year, KFSHRC has been ranked first in the Middle East and Africa and 15th globally in the list of the world's top 250 Academic Medical Centers. According to the 2025 Brand Finance rankings, it is recognized as the most valuable healthcare brand in the Kingdom and the Middle East. Additionally, it was included in Newsweek magazine's World's Best Smart Hospitals list for 2025.
Zawya
17-04-2025
- Business
- Zawya
Burjeel Holdings, Hippocratic AI partner to advance generative AI healthcare agents
Burjeel Holdings today announced a strategic partnership with Hippocratic AI, the company that pioneered the first safety-focused generative AI healthcare agents, to transform healthcare delivery through safe, scalable, and empathetic AI. The initiative kicked off during the Abu Dhabi Global Healthcare Week. The collaboration will see Hippocratic AI's generative AI healthcare agents, built for patient-facing non-diagnostic clinical tasks, deployed across Burjeel Holdings' hospitals, medical centres, and physiotherapy clinics in the UAE and Oman. By integrating Hippocratic AI's cutting-edge AI capabilities, Burjeel Holdings aims to transform the patient engagement experience, providing personalised and compassionate clinical conversations that address patient needs. Their introduction aligns with the Group's commitment to integrating advanced technology in healthcare while maintaining a human-centric approach. John Sunil, Group Chief Executive Officer of Burjeel Holdings, said, "At Burjeel Holdings, we believe that the future of healthcare lies in the perfect harmony between cutting-edge technology and personalised care. Our partnership with Hippocratic AI is a testament to our ongoing mission to leverage AI to improve patient experience, efficiency, reduce wait times, and ultimately provide better health outcomes for our patients." What sets these agents apart is their ability to engage in natural, safety-focused, human-like conversations. Through the integration of Hippocratic AI's multilingual, empathy-driven agents, Burjeel Holdings will deliver real-time, culturally aware support across a wide range of patient touchpoints, including appointment scheduling, patient education, health risk assessments, and follow-up check ins. These advanced agents are capable of sustained, multi-turn dialogue, enabling them to provide consistent, compliant, and compassionate communication that enhances both the patient experience and care continuity. Munjal Shah, Co-Founder and CEO of Hippocratic AI, said, "This partnership supports our shared mission of achieving healthcare abundance. Our empathic genAI agents are designed to create a more compassionate and effective patient experience. Together, we will tailor our solutions to meet the specific needs of the communities we serve." Key highlights of the partnership include the deployment of multilingual AI agents, including Arabic and the Emirati dialect, ensuring effective communication with the region's diverse patient population. The collaboration will also deliver customised regional generative AI agents tailored for cultural alignment and local relevance, enhancing the quality and empathy of patient interactions. In addition, AI agents will be deployed across key specialities such as oncology, cardiology, neurology, and orthopaedics, supporting both clinical and administrative tasks to help streamline operations and elevate the patient experience. The partnership focuses on expanding the deployment of these genAI healthcare agents across Burjeel Holdings' facilities, ensuring that healthcare providers can access the latest advancements in technology and patient support. Incorporating AI technologies into the complex care environment aligns with Burjeel Holdings' commitment to transforming healthcare delivery across critical areas. This collaboration reflects a shared vision: harnessing safety-focused generative AI to support healthcare systems, ease staffing challenges, and deliver hyper-personalised, compassionate care - advancing the collective goal of healthcare abundance.
Al Etihad
17-04-2025
- Health
- Al Etihad
Oliver Wyman backs Abu Dhabi's vision to become global healthcare leader
17 Apr 2025 14:51 ABU DHABI (WAM)Global consulting firm Oliver Wyman, the knowledge partner of Abu Dhabi Global Healthcare Week 2025, has reiterated its support for Abu Dhabi's ambition to establish itself as a leading global hub for healthcare and life sciences by promoting innovation, expanding international collaboration, and sharing expert statements to the Emirates News Agency (WAM), Sumit Sharma, Partner and Head of Health and Life Sciences in India, the Middle East, and Africa, said that Abu Dhabi has positioned itself as a rising global player in healthcare. He emphasised the need to build on this momentum by cultivating an ecosystem that encourages innovation and described Abu Dhabi Global Healthcare Week as a key platform that brings together global experts and decision-makers to explore investment opportunities and forge new Wyman will play an active role at the event by organising and participating in expert panels and contributing to strategic discussions aimed at advancing healthcare quality and also announced the launch of a new research paper during the week, which will focus on two priority areas: faster access to medicines and mental health. The paper aligns with Abu Dhabi's broader goals to enhance quality of life and promote long-term healthcare sustainability. He underlined the importance of the study, which is being developed in collaboration with local regulators, as a step toward creating a global healthcare model that puts human well-being at the centre and is driven by innovation and knowledge.
